MINNEAPOLIS (AP) -- Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft. The world's largest medical device ...

For the first time, U.S. regulators have cleared Medtronic's controversial Infuse Bone Graft biologic product for lower-back surgery for use with plastic — rather than titanium — spinal components.

A study comparing the safety and effectiveness of Infuse Bone Graft material to autogenous bone graft when used in maxillary sinus floor augmentation demonstrated that Infuse has similar rates of ...

Medtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and confirmed that the randomised controlled trial of INFUSE Bone Graft in the ...

In response to their prior inquiries, Medtronic Spine President Douglas King wrote letters to Minnesota Senators Al Franken and Amy Klobuchar, stating the adverse events that occurred during a study ...

Minneapolis-based Medtronic faces approximately 700 lawsuits involving 1,000 patients claiming personal injury due to the company’s Infuse bone graft product, according to the company’s SEC filing for ...

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) has initiated proceedings in the Federal Court of Australia against Medtronic Australasia Pty Ltd. for alleged unlawful supply of ...

SAN FRANCISCO (MarketWatch) -- Medtronic Inc. said late Monday the Food and Drug Administration has granted an investigational device exemption for a clinical trial to study the Infuse bone graft in a ...

June 2 (Reuters) - Managed care company Humana Inc has filed a lawsuit against Medtronic Inc accusing the medical device maker of falsely representing its Infuse bone growth-stimulation product as ...

MINNEAPOLIS (AP) — Medtronic says federal prosecutors have closed their investigation of the Minneapolis-based company’s InFuse bone graft. The medical device maker was being investigated by the U.S.